staceywhite, Author at European Medical Journal - Page 98 of 194

An Interview with Eric Peacock from MyHealthTeams

An interview with Eric Peacock, Co-Founder and CEO of MyHealthTeams, at Cannes Lions 2018 who discusses patient engagement through social networks and…

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies…

The European Medical Journal Presents: EMJ Allergy & Immunology 3.1

The European Medical Journal has published the latest edition of the EMJ Allergy & Immunology eJournal, which includes a comprehensive review of this…

Multiplex Component-Based Allergy Diagnostics

In vitro assays for specific IgE based on purified allergen components (defined partial allergen diagnostics, DPA-Dx) provide in-depth characterisation…

European Medical Journal Presents: EMJ Nephrology 6.1

The publication of EMJ Nephrology 6.1 is now available and features a full review of the ERA-EDTA 2018 Congress, this year held in Copenhagen, Denmark.

Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer…

European Medical Journal Presents: EMJ Interventional Cardiology 6.1

The eagerly awaited EMJ Interventional Cardiology 6.1, offering a comprehensive and independent review of EuroPCR 2018, is now available for all to enjoy.

"Patient, trust, reputation, and business. Those four areas, in that order of priority, are how we go about our work."

Patient, Trust, Reputation, Business: the starting point of EMG’s conversation with Dion Warren and the pillars that underpin the talk with the Head of…

GOLD – A new pharma magazine by EMG

With bold and cutting-edge content, this first issue brings you the current trends and challenges of the pharma industry, from thought leaders and top…

Exciting Potential New Treatment for T Cell Leukaemia

Many T cell leukaemia patients could be treated by a drug which suppresses the BCL-2 protein, according to researchers from KU Leuven, Leuven, Belgium.